Remember when the cineplex concept debuted and a family could pile into the car for a trip to one big theater where everyone could see a different movie at the same time in the same place? In recent years, longtime NIH grantee Dr. Jay Shendure has been focused on applying a similar idea to genome science.
When eosinophils stay where they are supposed to—that is, not in the lung, esophagus or skin—they are useful, even beautiful, says Dr. Amy Klion, senior clinical investigator and head of the human eosinophil section of NIAID’s Laboratory of Parasitic Diseases.
Like the hosts within which they reside, eosinophils can be troublemakers or helpmates.
OITE director Dr. Sharon Milgram makes it a priority to assure that trainees from different backgrounds feel comfortable and included while pursuing research at NIH. Milgram was among the speakers at NIH's Pride in Diversity Sexual and Gender Minority Community and Ally Leader Awards Program.
When Tom Kaminski was 7 years old, he had what doctors simply described as a hole in his heart. Officially, it was a congenital heart defect known as tetralogy of Fallot, which caused oxygen-poor blood to flow through his body and turn his lips and fingernails blue. But for Tom the details of his diagnosis were the least of his concerns.
On the Cover
A mouse neural stem cell (blue and green) sits in a lab dish atop a special gel containing a mat of synthetic nanofibers (purple). The cell is growing and sending out spindly appendages called axons (green), in an attempt to reestablish connections with other nearby nerve cells. The research represents hope that one day humans may be able to reverse spinal cord damage.
Photo: Mark McClendon, Zaida Alvarez & Samuel I. Stupp, Northwestern University